Steve Elms, Director at Marker Therapeutics, Inc. (MRKR), bought 2,285,714 shares at $1.75 ($4.0M) on 2021-03-16, disclosed to the SEC on 2021-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 1,142,857 | $2.0M | 50.0% |
| 2 | $1.75 | 1,142,857 | $2.0M | 50.0% |
| Total | $1.75 avg | 2,285,714 | $4.0M | 100% |
| Filing → |
| MRKR | BUY | 2024-12-26 | $35K | — | Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |